Sandra Algarín-Perneth: The success of precision oncology guided by HER2 genomic profiling – a rare neuroendocrine carcinoma case

Sandra Algarín-Perneth, Postdoctoral Research Fellow in Gastroenterology and Hepatology at Mayo Clinic, shared on Twitter:

“Explore a rare neuroendocrine carcinoma case, demonstrating the success of precision oncology guided by HER2 genomic profiling. This emphasizes innovative treatments and advocates for broader HER2-positive clinical trial inclusion.

Grateful for the incredible mentors guiding me through this case report. Their expertise and support have been invaluable in shaping this important work. ”

For the article click here.
Source: Sandra Algarín-Perneth/Twitter